Thc Biomed Intl Stock Today
| THCBF Stock | USD 0 0.00 0.00% |
Performance7 of 100
| Odds Of DistressLess than 16
|
THC Biomed is trading at 0.001 as of the 23rd of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.001. THC Biomed has less than a 16 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for THC Biomed Intl are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of May 2024 and ending today, the 23rd of November 2024. Click here to learn more.
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States. The company has 163.96 M outstanding shares. More on THC Biomed Intl
Moving against THC Pink Sheet
| 0.72 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.65 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.58 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.55 | KEP | Korea Electric Power | PairCorr |
| 0.51 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.48 | WMT | Walmart Aggressive Push | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
THC Pink Sheet Highlights
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
THC Biomed Intl [THCBF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate THC Biomed's market, we take the total number of its shares issued and multiply it by THC Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. THC Biomed Intl classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 163.96 M outstanding shares.
THC Biomed Intl has accumulated about 1.16 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check THC Biomed Probability Of Bankruptcy
Ownership AllocationTHC Biomed Intl secures a total of 163.96 Million outstanding shares. THC Biomed Intl shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check THC Ownership Details
THC Biomed Intl Risk Profiles
| Mean Deviation | 16.73 | |||
| Semi Deviation | 17.53 | |||
| Standard Deviation | 35.76 | |||
| Variance | 1278.8 |
THC Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in THC Biomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
THC Biomed Corporate Management
| Damien Reynolds | Chief Officer | Profile | |
| Dianne FCIS | Co Sec | Profile | |
| John Miller | CEO Pres | Profile | |
| Jung Hee | CFO CoFounder | Profile |
Other Information on Investing in THC Pink Sheet
THC Biomed financial ratios help investors to determine whether THC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in THC with respect to the benefits of owning THC Biomed security.